Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC. (Q48066669)
scientific article published in February 1996
Language:
Current Data About Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
(P31) (Q13442814)
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P304) 99-107
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P433) 2
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P478) 42
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P577) Thursday, February 1, 1996
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P1433) (Q5031409)
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P1476) "Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC." (language: en)
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

(P2093) Panelli MC
(P1545) 1
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Wang E
(P1545) 2
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Shen S
(P1545) 3
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Schluter SF
(P1545) 4
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Bernstein RM
(P1545) 5
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Hersh EM
(P1545) 6
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Stopeck A
(P1545) 7
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Gangavalli R
(P1545) 8
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Barber J
(P1545) 9
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Jolly D
(P1545) 10
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

Akporiaye ET
(P1545) 11
(P248)
(P698) 8620527
(P813) Thursday, February 8, 2018
(P854) http://europepmc.org/abstract/MED/8620527

other details
description scientific article published in February 1996

External Links
(P356) 10.1007/S002620050258
(P698) 8620527